Претраживање
Приказ резултата 1-10 од 19
Serologic rebounds after one-year-long treatment for congenital toxoplasmosis
(Lippincott Williams & Wilkins, Philadelphia, 2000)
Murine model of drug-induced reactivation of Toxoplasma gondii
(Jagiellonian Univ, Inst Environmental Sciences, Krakow, 2001)
A murine model of recrudescence of chronic toxoplasmosis, mimicking this life-threatening condition in immunosuppressed humans, was developed in Swiss-Webster mice infected 6 weeks previously with 10 cysts of the Me49 ...
Comparison of a commercial ELISA with the modified agglutination test for the detection of Toxoplasma gondii infection in naturally exposed sheep
(Wiley, Hoboken, 2007)
Surprisingly few commercial ELISAs are available for the detection of Toxoplasma gondii infection in animals, and none for use in sheep have been evaluated. We thus compared the Bommeli Diagnostics ELISA Toxotest for the ...
Treatment protocol determines the efficacy of clindamycin in acute murine toxoplasmosis
(Elsevier, Amsterdam, 1999)
To determine the contribution to the efficacy of clindamycin in acute murine toxoplasmosis of treatment protocol variables, groups of Swiss Webster mice inoculated intraperitoneally with 10(2) RH strain Toxoplasma gondii ...
Cross-sectional survey on Toxoplasma gondii infection in cattle, sheep and pigs in Serbia: Seroprevalence and risk factors
(Elsevier Science Bv, Amsterdam, 2006)
Toxoplasmosis is a globally distributed zoonosis with a clinical impact in the unborn fetus and in the immunosuppressed individual. In Serbia, studies of risk factors for Toxoplasma gondii infection in humans have shown ...
A human origin type II strain of Toxoplasma gondii causing severe encephalitis in mice
(Elsevier Science Bv, Amsterdam, 2006)
Despite its capacity for sexual reproduction and global distribution, Toxoplasma gondii has a highly clonal structure, with the majority of isolates belonging to three distinct clonal types. Congenital toxoplasmosis has ...
Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis
(Elsevier, Amsterdam, 2005)
The antitoxoplasmic activity of spiramycin (SPI) was evaluated in murine models of infection using a type-1 (RH) or type-2 (Me49) strain of Toxoplasma gondii. In mice infected with 10(2) tachyzoites of the RH strain, ...
Granulopoiesis during acute Toxoplasma gondii infection in mice
(Univerzitet u Beogradu - Fakultet veterinarske medicine, Beograd, 1997)
There is little evidence for the role of granulocytes in the host defence against the protozoan parasite Toxoplasma gondii. Thus, the purpose of this study was to assess the involvement of granulocytes during acute murine ...
Animal reservoirs of Toxoplasma gondii : An update in France / Animaux réservoirs de Toxoplasma gondii: état des lieux en France
(Revue Francophone des Laboratoires, 2015)
Toxoplasmosis is a disease widely distributed throughout the world. It is caused by Toxoplasma gondii, a protozoan parasite, having the Felidae as final host (the cat) and warm-blooded vertebrates as intermediate hosts. ...
Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate
(Elsevier, Amsterdam, 2005)
The mouse-virulent RH strain of Toxoplasma gondii is generally considered to have lost its cyst-forming capacity, and conversion of RH tachyzoites into cysts in non-immune mice has previously been shown exclusively following ...